Licensed vaccine
Vaxchora
FDA-licensed vaccine · Bavarian Nordic A/S · STN 125597
Key facts
| Trade name | Vaxchora |
|---|---|
| Proper name | Cholera Vaccine Live Oral |
| Manufacturer | Bavarian Nordic A/S |
| Submission tracking number (STN) | 125597 |
| FDA product areas | Biologics |
| Recent FDA documents | Package Insert - VAXCHORA, June 11, 2024 Approval Letter - VAXCHORA, December 12, 2022 Approval Letter - VAXCHORA, Statistical Review - VAXCHORA, Clinical Review - VAXCHORA, December 23, 2020 Approval Letter - VAXCHORA, February 13, 2020 Approval Letter - VAXCHORA, Approval History, Letters, Reviews, and Related Documents - VAXCHORA, Supporting Documents older than three years - VAXCHORA |
| FDA page updated | Jun 12, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: